Literature DB >> 9497952

Prostatic meningeal carcinomatosis presenting as delirium tremens.

J B Rubins1, M J Guzman-Paz.   

Abstract

We report an unusual case of prostatic carcinomatous meningitis and remind clinicians to maintain a high index of suspicion of meningeal involvement when patients with advanced prostatic cancer present with cerebral symptoms, back pain, or neurologic findings. The diagnosis may require repeated cytologic examinations of cerebrospinal fluid, and immunocytochemical stains should be considered to confirm a prostatic source if malignant cells are identified. Androgen ablative therapy may give prolonged remissions, especially in patients with previously untreated tumours.

Entities:  

Mesh:

Year:  1997        PMID: 9497952      PMCID: PMC2431517          DOI: 10.1136/pgmj.73.866.810

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  6 in total

Review 1.  Neoplastic meningitis.

Authors:  S A Grossman; T J Moynihan
Journal:  Neurol Clin       Date:  1991-11       Impact factor: 3.806

2.  Infiltration of the leptomeninges by systemic cancer. A clinical and pathologic study.

Authors:  M E Olson; N L Chernik; J B Posner
Journal:  Arch Neurol       Date:  1974-02

3.  Pathogenesis of meningeal carcinomatosis. Report of a case secondary to carcinoma of cecum via perineural extension; with a review of 146 cases.

Authors:  D L Herman; C B Courville
Journal:  Bull Los Angeles Neurol Soc       Date:  1965-09

4.  Cytopathology of nonlymphoreticular neoplasms metastatic to the central nervous system.

Authors:  H Ehya; S I Hajdu; M R Melamed
Journal:  Acta Cytol       Date:  1981 Nov-Dec       Impact factor: 2.319

5.  Hormonal ablation as effective therapy for carcinomatous meningitis from prostatic carcinoma.

Authors:  P J Mencel; L M DeAngelis; R J Motzer
Journal:  Cancer       Date:  1994-04-01       Impact factor: 6.860

6.  Meningeal carcinomatosis secondary to prostatic carcinoma: case report.

Authors:  P S Mahadevia; T M Kiely
Journal:  J Urol       Date:  1980-07       Impact factor: 7.450

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.